Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m

Asahi Kasei plans to use its infrastructure and R&D to accelerate development and commercialisation of Aicuris’s pipeline. Credit: alicancomertpay / Shutterstock.com.